New Vaccine For Syphilis Finaly Discoverd

A s part of global efforts to tackle syphilis, scientists have come up with new discoveries that would make a vaccine that would possibly prevent the disease

According to findings, the UConn Health researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis disease. Although, Syphilis is hard to study because, unlike many disease causing bacteria, it cannot be grown in a laboratory dish or in mice.

Besides humans, the only animal commonly found in laboratories that is susceptible to syphilis is the rabbit.

But rabbits clear syphilis infections quickly, so the researchers plan to regularly infect new rabbits to maintain a strain of Treponema pallidum, the syphilis-causing bacteria to pave the way for achieving the vaccine. The study is published in the 12 June issue of ‘mBio,’ a bimonthly peer-reviewed open access scientific journal published by the American Society for Microbiology in association with the American Academy of Microbiology.

UConn Health is a renowned biomedical research centre, specialising in genetics, ageing, orthopaedics and neurology at the University of Connecticut School of Medicine.

 Syphilis is a sexually transmitted disease (STD) that can have very serious complications when left untreated, but it is simple to cure with the right treatment and symptoms of secondary syphilis include skin rash, swollen lymph nodes, and fever. Spread by sexual contact, syphilis disease starts as a painless sore — typically on the genitals, rectum or mouth. Similarly, it spreads from person to person via skin or mucous membrane contact with these sores. In spite of global efforts to eradicate it, syphilis is on the ris

Although, until now, most health agencies focused on treating infected people and their sex partners, which has so far limited that approach considering that many partners do not turn up for treatment, thereby jeopardising the efforts to reduce syphilis spread. However, the new discoveries may produce a vaccine that could tackle the disease, is widely seen as an effort in the right direction.